Radiotherapy Increases Risk of Death From Cardiac Disease

Article

Radiotherapy may increase the long-term risk of death from cardiovascular disease, especially in women with left-sided breast cancer who are treated with contemporary tangential breast or chest-wall radiotherapy, according to a study in the Jan. 25 issue of the Journal of the American College of Cardiology.

THURSDAY, Jan. 20 (HealthDay News) -- Radiotherapy may increase the long-term risk of death from cardiovascular disease, especially in women with left-sided breast cancer who are treated with contemporary tangential breast or chest-wall radiotherapy, according to a study in the Jan. 25 issue of the Journal of the American College of Cardiology.

Kim Bouillon, M.D., M.P.H., from the Universite Paris-Sud in Villejuif, France, and colleagues studied 4,456 women diagnosed with breast cancer between 1954 and 1984, who survived for at least five years after breast cancer radiotherapy treatment. Participants were followed for an average of 28 years to assess mortality rates.

The investigators identified a total of 421 deaths due to cardiovascular diseases, 236 of which were due to cardiac disease. Women who had undergone radiotherapy had a 1.76-fold increased risk of dying from cardiac disease and a 1.33-fold increased risk of dying from vascular disease compared with those who had not received radiotherapy. Women who were treated for left-sided breast cancer had a 1.56-fold increased risk of death from cardiac disease compared with those treated for right-sided breast cancer. The relative risk increased with time after the diagnosis of breast cancer (P = 0.05).

"Our results confirm that radiotherapy for breast cancer, such as that practiced until the mid-1980s, increased the long-term risk of death from cardiac disease. The excess mortality due to cardiac disease was significantly higher following radiotherapy for left-sided than for right-sided breast cancer," the authors write.

AbstractFull Text (subscription or payment may be required)Editorial (subscription or payment may be required)

Related ContentTreatment Modalities for Female Genital Cancer (Radiotherapy) Survival rates same for conservation treatment or mastectomy for recurrent DCIS

Related Videos
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Related Content
© 2024 MJH Life Sciences

All rights reserved.